{"id":"tp-1261","type":"article-newspaper","title":"Boehringer Ingelheim and IBM Canada to explore blockchain potential in clinical trials","author":"Shampa Mani","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/technology/1261","datePublished":"2019-02-13T06:20:49.000Z","dateModified":"2019-02-13T06:20:49.000Z","language":"en","abstract":"Pharmaceutical giant Boehringer Ingelheim (Canada) is teaming up with IBM Canada to look into the use of blockchain technology in clinical trials.","section":"Technology","references":[{"title":"Boehringer Ingelheim","url":"https://www.boehringer-ingelheim.ca/en"},{"title":"blockchain technology in clinical trials","url":"https://www.prnewswire.com/news-releases/boehringer-ingelheim-canada-ltd-and-ibm-canada-announce-first-of-its-kind-collaboration-to-integrate-blockchain-technology-into-clinical-trials-300793658.html"},{"title":"Donate","url":"https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=GD9D8CPW8HFA2"}]}